361 related articles for article (PubMed ID: 12242464)
1. The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice.
Yang ZD; Chen M; Wu R; McDuffie M; Nadler JL
Diabetologia; 2002 Sep; 45(9):1307-14. PubMed ID: 12242464
[TBL] [Abstract][Full Text] [Related]
2. The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation.
Yang Z; Chen M; Ellett JD; Fialkow LB; Carter JD; Nadler JL
Transplantation; 2004 Jan; 77(1):55-60. PubMed ID: 14724435
[TBL] [Abstract][Full Text] [Related]
3. The novel anti-inflammatory compound, lisofylline, prevents diabetes in multiple low-dose streptozotocin-treated mice.
Yang Z; Chen M; Fialkow LB; Ellett JD; Wu R; Nadler JL
Pancreas; 2003 May; 26(4):e99-104. PubMed ID: 12717280
[TBL] [Abstract][Full Text] [Related]
4. Xenografts of porcine islets immunoprotected in hollow fibres reduce the incidence of diabetes in non-obese diabetic mice.
Chaillous L; Darquy S; Maugendre S; Rivereau AS; Reach G; Saï P
Diabetologia; 1996 May; 39(5):523-9. PubMed ID: 8739911
[TBL] [Abstract][Full Text] [Related]
5. N-acetyl-cysteine accelerates transfer of diabetes into non-obese diabetic scid mice.
Irie J; Shimada A; Oikawa Y; Shigihara T; Saruta T
Diabetologia; 2004 Oct; 47(10):1803-9. PubMed ID: 15502923
[TBL] [Abstract][Full Text] [Related]
6. Lisofylline, a novel antiinflammatory agent, protects pancreatic beta-cells from proinflammatory cytokine damage by promoting mitochondrial metabolism.
Chen M; Yang Z; Wu R; Nadler JL
Endocrinology; 2002 Jun; 143(6):2341-8. PubMed ID: 12021199
[TBL] [Abstract][Full Text] [Related]
7. Sodium meta-arsenite prevents the development of autoimmune diabetes in NOD mice.
Lee YS; Kim D; Lee EK; Kim S; Choi CS; Jun HS
Toxicol Appl Pharmacol; 2015 Apr; 284(2):254-61. PubMed ID: 25576766
[TBL] [Abstract][Full Text] [Related]
8. Inflammation blockade improves pancreatic islet function.
Yang Z; Chen M; Carter JD; Ellett JD; Smith KM; Nadler JL
Transplant Proc; 2004 Nov; 36(9):2864-5. PubMed ID: 15621169
[TBL] [Abstract][Full Text] [Related]
9. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse.
Calcinaro F; Dionisi S; Marinaro M; Candeloro P; Bonato V; Marzotti S; Corneli RB; Ferretti E; Gulino A; Grasso F; De Simone C; Di Mario U; Falorni A; Boirivant M; Dotta F
Diabetologia; 2005 Aug; 48(8):1565-75. PubMed ID: 15986236
[TBL] [Abstract][Full Text] [Related]
10. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
[TBL] [Abstract][Full Text] [Related]
11. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
[TBL] [Abstract][Full Text] [Related]
12. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
[TBL] [Abstract][Full Text] [Related]
13. Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice.
Gerling IC; Serreze DV; Christianson SW; Leiter EH
Diabetes; 1992 Dec; 41(12):1672-6. PubMed ID: 1446808
[TBL] [Abstract][Full Text] [Related]
14. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content.
Füchtenbusch M; Larger E; Thebault K; Boitard C
Horm Metab Res; 2005 Feb; 37(2):63-7. PubMed ID: 15778920
[TBL] [Abstract][Full Text] [Related]
15. [Oral administration of insulin inhibits islet beta cell apoptosis and prevents diabetes in NOD mice].
Jiang TJ; Zhou ZG
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):615-9. PubMed ID: 17767052
[TBL] [Abstract][Full Text] [Related]
16. Neonatal injections of cyclosporin enhance autoimmune diabetes in non-obese diabetic mice.
Saï P; Senecat O; Martignat L; Gouin E
Clin Exp Immunol; 1994 Jul; 97(1):138-45. PubMed ID: 8033411
[TBL] [Abstract][Full Text] [Related]
17. Effects of interleukin-12 in vitro on pancreatic islets isolated from normal rodents and from non-obese diabetic mice.
Sternesjö J; Sandler S
J Endocrinol; 1998 Jul; 158(1):69-75. PubMed ID: 9713328
[TBL] [Abstract][Full Text] [Related]
18. IFN-γ induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice.
Zhang J; Huang Z; Sun R; Tian Z; Wei H
J Autoimmun; 2012 Feb; 38(1):20-8. PubMed ID: 22186068
[TBL] [Abstract][Full Text] [Related]
19. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice.
Tominaga Y; Nagata M; Yasuda H; Okamoto N; Arisawa K; Moriyama H; Miki M; Yokono K; Kasuga M
Clin Immunol Immunopathol; 1998 Feb; 86(2):209-18. PubMed ID: 9473384
[TBL] [Abstract][Full Text] [Related]
20. Preventive effects of andrographolide on the development of diabetes in autoimmune diabetic NOD mice by inducing immune tolerance.
Zhang C; Gui L; Xu Y; Wu T; Liu D
Int Immunopharmacol; 2013 Aug; 16(4):451-6. PubMed ID: 23707775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
